Several therapeutic strategies harness lymphocytes to treat cancer. One approach is adoptive cell transfer (ACT), which involves isolating lymphocytes from a patient, expanding or modifying them in the laboratory, and reinfusing them into the patient. A prominent example is [CAR-T cell therapy](https://), where T cells are genetically engineered to express chimeric antigen receptors (CARs) that target specific cancer antigens.
